Archive: Innovative Type 1 Diabetes Approach Licensed to Encellin
Encellin obtained exclusive rights from UCSF for a proprietary cell encapsulation technology aimed at improving physicians’ ability to perform cell transplants without the need for immunosuppressive drugs.